(1888PressRelease)
May 29, 2009 - According to our research report “US Stem Cell Market Analysis”, the stem cell market for therapy purposes in the US is expected to grow at a CAGR of around 34% during 2008-2012 to reach US$ 469.2 Million by 2012. The success of the stem cell market largely depends on the promptness in public acceptance of the therapy, obtaining regulatory approvals and the degree of the benefit derived out of the treatment.
Favorable regulatory conditions make the US a perfect place to conduct stem cell research. The market is opened to conduct embryonic stem cell research, which is considered to possess more potential from the commercial point of view for the treatment of various types of diseases.
Initially, the country had two stem cell products in the market. With growing awareness about the potential therapeutic applications of stem cells and rising interest of the medical practitioners in the subject, more products are likely to enter the market. The sales of stem cell products in 2008 grew by 144% to reach US$ 87 Million and are expected to climb to around US$ 900 Million by 2012.
Moreover, the country has large proportion of the population suffering from various severe diseases. As the stem cells have proved very effective in the treatment of several diseases, the patients are looking for more discoveries of effective treatments using stem cell technology in therapy areas.
With the medical community realizing the hidden potential of the stem cell technology to develop effective treatments for chronic illnesses that can be far more superior in efficacy over the prevailing treatments, the cellular therapeutics market is expected to grow at a faster rate compared to therapeutic banking.
"US Stem Cell Market Analysis" provides comprehensive information and rational analysis of current industry trends driving growth in the US stem cell market. The report identifies the emerging segments in the stem cell market along with their market potential to provide effective and reliable treatment for the chronic diseases. The report will help clients to understand the market dynamics and align their investment strategies.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM191.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
###
